Caricamento...
Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
To overcome the side effects of and resistance to cisplatin, a variety of Pt(IV) prodrugs were designed and synthesized via different modifications including combination with lipid chains to increase hydrophobicity, conjugation with short peptide chains or nanoparticles to improve drug delivery, or...
Salvato in:
| Pubblicato in: | Bioinorg Chem Appl |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6191961/ https://ncbi.nlm.nih.gov/pubmed/30402082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8276139 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|